CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 144-150
作者:  He, Dalin;  Sun, Zhongquan;  Guo, Jianming;  Zhang, Zhigen;  Shan, Yuxi
收藏  |  浏览/下载：22/0  |  提交时间：2020/01/03
Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population 期刊论文
2019, 卷号: 6, 期号: 1, 页码: 114-121
作者:  Zhou Liqun;  Yang Kaiwei;  Li Xuesong;  Ding Yi;  Mu Dawei
收藏  |  浏览/下载：57/0  |  提交时间：2020/01/03
RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis 期刊论文
2018, 卷号: 18, 期号: 1, 页码: 195
作者:  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Ridolfi, Antonia;  Dezzani, Luca
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文
2017, 卷号: 4, 期号: 2, 页码: 75-85
作者:  Ye Dingwei;  Huang Yiran;  Zhou Fangjian;  Xie Keji;  Matveev Vsevolod
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04
RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-01-10
作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study 期刊论文
2016, 卷号: 23, 期号: 5, 页码: 404-411
作者:  Sun, Yinghao;  Zou, Qing;  Sun, Zhongquan;  Li, Changling;  Du, Chuanjun
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Anlotinib in metastatic renal cell carcinoma (mRCC) with a previous anti-VEGFR TKI: Preliminary results from a multicenter, phase II trial. 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Van;  Li, Hangzhong;  Xie, Xiaodong
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace